Zenox was across this news and posted the link to results of the WARMTH study on 26/5, way before the market announcement.
That's the value of this forum, great insights from posters, like Goldstar looking investigating who was behind the recent sell offs, or Zecs finds on the patent front, Rbx’s ongoing insights.
Not scrapping with Vrs. The scrapping that goes on about obvious weak arguments detracts from the discussions we could be having.
This company remains hopelessly undervalued just on prospects in treating prostate ca alone and ignoring the other 3 pillars, particularly when you consider there’s 30 mil cash and they own 10 mil worth of Nyrada. What are we going to do if it works in COVID/sepsis as well? Exciting times ahead.
- Forums
- ASX - By Stock
- NOX
- Ann: New Independent Trial Data Supports Potential of Veyonda
Ann: New Independent Trial Data Supports Potential of Veyonda, page-12
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.28M |
Open | High | Low | Value | Volume |
6.6¢ | 6.6¢ | 6.6¢ | $336 | 5.089K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14893 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 55096 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14893 | 0.067 |
1 | 200000 | 0.066 |
1 | 7703 | 0.065 |
1 | 100000 | 0.064 |
1 | 15401 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 55096 | 2 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 25689 | 3 |
Last trade - 11.03am 01/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online